Pfizer Reports European Approval for Label Update Related to Prevenar 13
October 17, 2013 at 07:15 AM EDT
Pfizer Inc. (NYSE: PFE ) announced today that the European Commission approved updates to the Summary of Product Characteristics (SmPC) for the company's pneumococcal conjugate vaccine Prevenar 13* (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), regarding its use in certain populations at high risk of pneumococcal disease. The updated label now includes information describing the
